Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Scuderi

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
BJU International|October 3, 2025
Re: 'Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review'Simone Scuderi, Giorgio Gandaglia, Alberto Briganti, et al.
European Urology|August 20, 2025
Re: Prostate Cancer: A ReviewSimone Scuderi, Giorgio Gandaglia, Alberto Briganti, et al.
European Urology|February 11, 2023
Re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80Francesco Montorsi, Simone Scuderi, Alberto Briganti, et al.
European Urology|February 11, 2023
Re: Kerrington Powell, Michael C. Burns, Vinay Prasad. Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint. Eur Urol. 2023;83:101-2Francesco Montorsi, Simone Scuderi, Alberto Briganti, et al.
European Urology|October 2, 2024
Re: Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic ReviewFrancesco Montorsi, Paolo Capogrosso, Simone Scuderi, et al.
European Urology|February 12, 2026
Re: Optimal Duration of Androgen Deprivation Therapy with Definitive Radiotherapy for Localized Prostate Cancer. A Meta-analysisAlessandro Viti, Simone Scuderi, Alberto Briganti, et al.
European Urology|June 29, 2026
Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysisAlessandro Viti, Simone Scuderi, Vito Cucchiara, et al.
European Urology Open Science|May 14, 2023
Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate CancerSimone Scuderi, Amy Tin, Giorgio Gandaglia, et al.
Cancers|May 14, 2025
The Role of Robot-Assisted, Imaging-Guided Surgery in Prostate Cancer PatientsLeonardo Quarta, Donato Cannoletta, Francesco Pellegrino, et al.
European Urology|January 9, 2020
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 TrialAlberto Briganti, Giorgio Gandaglia, Simone Scuderi, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
BJU International|October 3, 2025
Re: 'Real-world use of androgen-deprivation therapy intensification for metastatic hormone-sensitive prostate cancer: a systematic review'Simone Scuderi, Giorgio Gandaglia, Alberto Briganti, et al.
European Urology|August 20, 2025
Re: Prostate Cancer: A ReviewSimone Scuderi, Giorgio Gandaglia, Alberto Briganti, et al.
European Urology|February 11, 2023
Re: Melline G.M. Schilham, Mark Rijpkema, Tom Scheenen, et al. How Advanced Imaging Will Guide Therapeutic Strategies for Patients with Newly Diagnosed Prostate Cancer in the Years to Come. Eur Urol 2022;82:578-80Francesco Montorsi, Simone Scuderi, Alberto Briganti, et al.
European Urology|February 11, 2023
Re: Kerrington Powell, Michael C. Burns, Vinay Prasad. Relugolix: Five Reasons Why the US Food and Drug Administration Should Have Exercised Restraint. Eur Urol. 2023;83:101-2Francesco Montorsi, Simone Scuderi, Alberto Briganti, et al.
European Urology|October 2, 2024
Re: Bladder Outlet Obstruction Relief and Symptom Improvement Following Medical and Surgical Therapies for Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia: A Systematic ReviewFrancesco Montorsi, Paolo Capogrosso, Simone Scuderi, et al.
European Urology|February 12, 2026
Re: Optimal Duration of Androgen Deprivation Therapy with Definitive Radiotherapy for Localized Prostate Cancer. A Meta-analysisAlessandro Viti, Simone Scuderi, Alberto Briganti, et al.
European Urology|June 29, 2026
Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysisAlessandro Viti, Simone Scuderi, Vito Cucchiara, et al.
European Urology Open Science|May 14, 2023
Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate CancerSimone Scuderi, Amy Tin, Giorgio Gandaglia, et al.
Cancers|May 14, 2025
The Role of Robot-Assisted, Imaging-Guided Surgery in Prostate Cancer PatientsLeonardo Quarta, Donato Cannoletta, Francesco Pellegrino, et al.
European Urology|January 9, 2020
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 TrialAlberto Briganti, Giorgio Gandaglia, Simone Scuderi, et al.
Pageof 7